N.J. Stat. § 17B:27F-3

Current through L. 2024, c. 87.
Section 17B:27F-3 - [Effective Until 1/1/2025] Requirements for placing prescription drug on multiple source generic list
a. In order to place a particular prescription drug on a multiple source generic list, the pharmacy benefits manager shall, at a minimum, ensure that:
(1) The drug is listed as therapeutically and pharmaceutically equivalent or "A," "B," "NR," or "NA" rated in the Food and Drug Administration's most recent version of the Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the "Orange Book;" and
(2) The drug is available for purchase without limitations by all pharmacies in the State from national or regional wholesalers and is not obsolete or temporarily unavailable.
b. A pharmacy benefits manager shall not penalize a pharmacist or pharmacy on audit if the pharmacist or pharmacy performs a generic substitution pursuant to the "Prescription Drug Price and Quality Stabilization Act," P.L. 1977, c.240 (C.24:6E-1 et seq.).

N.J.S. § 17B:27F-3

Added by L. 2015, c. 179,s. 3, eff. 4/10/2016.
This section is set out more than once due to postponed, multiple, or conflicting amendments.